Developer docs
API playgroundTry for free, no card

Search company profiles

Cauldron Ferm

Full company profile

uuid00009ym

Namestring
Cauldron Ferm
Legal namestring
Cauldron Molecules Pty Ltd
Company typeenum
Private
Founded yearint
2022
Descriptiontext

Cauldron Ferm is an Australian precision fermentation biomanufacturing company founded in 2022 in Orange, NSW, that operates a contract manufacturing platform enabling synthetic biology companies to scale fermentation processes from laboratory to commercial production. The company's core offering is a proprietary "hyper-fermentation" continuous biomanufacturing technology — a continuous fermentation platform that addresses two chronic limitations of traditional fed-batch fermentation: contamination risk and genetic drift during extended runs. The platform is paired with ACE media, a set of fully defined, organism-specific nutrient formulations designed to prevent contamination in continuous culture. Together, these components underpin three tiered services: FermaFit (lab-scale technical fit evaluation), FermaValidate (10kL scale-up and techno-economic validation), and FermaGrow (commercial-scale production at 100kL+), with the company claiming 30-50% lower operational expenditure and 45% lower capital expenditure than incumbent batch fermentation.

The company monetizes primarily through multi-year enterprise contract manufacturing agreements, with a secondary stream from licensing its globally commercialized hyper-fermentation IP — acquired from Agritechnology in 2022, representing the product of 35 years of R&D. Pricing is quote-based across the three service tiers. The customer base is horizontal within synthetic biology — food protein developers, functional ingredient companies, and producers of animal-free compounds — with Nourish Ingredients (animal-free fats and proteins) disclosed as the first customer in 2023. Cauldron operates a 25,000-liter demonstration facility in Orange and is developing the Cauldron Bio-fab in Mackay, Queensland, intended to be Asia-Pacific's largest end-to-end precision fermentation contract manufacturer at 1,000+ tonnes/year.

The company has raised approximately $26 million in equity across four rounds (2023 seed, 2024 Series A, 2026 Series A2) led by Main Sequence Ventures and Horizons Ventures, with participation from SOSV, In-Q-Tel, and NGS Super. It has additionally secured roughly $8.9 million in non-dilutive government funding from the Australian Industry Growth Program, the U.S. Department of Defense, and Business.gov.au. Cauldron was recognized as a 2025 World Economic Forum Technology Pioneer and ranked #9 on Fast Company's Most Innovative Companies in Asia-Pacific 2026.

Short descriptiontext

Cauldron Ferm is an Australian precision fermentation contract manufacturer that uses its proprietary continuous hyper-fermentation platform to help synthetic biology companies scale food proteins, functional ingredients, and bio-based products from laboratory to commercial production.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersBorenore, Australia
HQ citystring
Borenore
HQ countrystring
Australia
HQ regionstring
Oceania
Markets served

Serves global market

Offices2 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
precision fermentation services, contract biomanufacturing, continuous fermentation platform, synthetic biology manufacturing, bioprocess scale-up
Industry2 codes
PRIMARYAFAFAIAG
Fermented/Probiotic Beverage Co-Packing (Kombucha, Kefir, Culture Drinks)
Agriculture & Food Production/Beverage Production/Contract Beverage Manufacturing & Co-Packing
SECONDARYAFAFAHAJ
Fermented Beverage Contract Manufacturing & Private Label
Agriculture & Food Production/Beverage Production/Fermented Beverage Production (Kombucha, Kefir, Probiotics)
NAICS code1 code
  • Beverage Manufacturing3121
SIC code1 code
  • Beverages2080
Product category
Precision Fermentation Contract Manufacturing
Social media profiles1 record
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model2 records
1Contract Biomanufacturing Services
TypeManaged Services
Description

Fee-for-service contract manufacturing using proprietary hyper fermentation platform. Provides three service tiers: FermaFit (technology evaluation), FermaValidate (10kL validation), and FermaGrow (commercial-scale production at 100kL+).

2Technology Licensing
TypeLicensing Royalties
Description

Licensing of proprietary hyper fermentation technology and IP acquired in 2022 seed round, now globally commercialized.

Marketing channels4 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels3 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Technology or R&D, Operations, Personnel, Infrastructure, Marketing or Sales
Pricing details3 tiers
1FermaFit - Technology evaluation tier
ModelOtherBilling cadenceMulti-year contract
Notes

Entry-level service for companies to evaluate hyper fermentation technology viability

2FermaValidate - 10kL validation tier
ModelOtherBilling cadenceMulti-year contract
Notes

Pilot-scale validation at 10,000L capacity for process validation and regulatory compliance

3FermaGrow - Commercial-scale production tier
ModelOtherBilling cadenceMulti-year contract
Notes

Full-scale commercial production at 100,000L+ capacity for market-ready products

GTM typeB2B
B2B
Offering typeServices
Services
Brand1 of 4 records shown
1FermaFit
Description

Technology transfer and evaluation of technical fit service for customers to transfer their technology and assess compatibility with Cauldron's continuous fermentation process.

cauldronferm.com
+3 more records
Core offering1 text field

Cauldron Ferm provides contract biomanufacturing services for precision fermentation, scaling customer fermentation processes from laboratory to commercial volumes using a proprietary continuous hyper-fermentation platform. Services are delivered through three tiers — FermaFit (technology evaluation), FermaValidate (10kL scale validation), and FermaGrow (100kL+ commercial production) — and supported by ACE media and proprietary bioprocess protocols. The company also licenses its hyper-fermentation technology IP for global commercialization.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 4 values shown
  • 30-50% reduction in operational costs compared to traditional batch fermentation
+3 more records
Product overview1 text field

Cauldron Ferm offers a platform-plus-services model for precision fermentation biomanufacturing. The core is its proprietary hyper-fermentation technology (continuous fermentation that solves contamination and genetic drift challenges), paired with ACE media (optimized growth media formulations). Services are delivered through three tiers: FermaFit (lab-scale technology transfer and technical fit evaluation), FermaValidate (10kL scale-up validation with techno-economic analysis), and FermaGrow (commercial-scale production at 100kL). The company operates demonstration facilities in Orange, NSW and is developing a commercial-scale facility in Mackay, Queensland.

Product and service3 records
1FermaFit
CategoryContract biomanufacturing services
Description

Technology transfer and evaluation service that assesses the technical fit of a customer's micro-organism with Cauldron's hyper-fermentation platform at lab-scale, including ACE media compatibility assessment. Targeted at precision fermentation companies beginning their scale-up journey.

2FermaValidate
CategoryContract biomanufacturing services
Description

Scale-up validation service at 10,000-litre scale that optimizes hyper-fermentation conditions and validates the techno-economic benefits for a customer's specific micro-organism, including COGS and output projections at 100kL scale. Targeted at synthetic biology companies ready to validate production economics before commercial-scale commitment.

3FermaGrow
CategoryContract biomanufacturing services
Description

Commercial-scale contract manufacturing service using hyper-fermentation to deliver low-cost production and commercial volumes at price parity with conventional products at 100,000-litre-plus capacity. Targeted at synthetic biology companies commercializing precision-fermented food proteins, ingredients, and other bio-based products.

Scale indicator8 records

Each record includes

Type, Value, Description, Source

Partnership3 partners
1Mackay BioFutures Hub
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2024-01-01
Description

Partnership for bioeconomy development at Mackay facility location. Provides infrastructure access and ecosystem positioning for first industrial-scale hyper fermentation facility.

Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2023-01-01
Description

Strategic partnership for scaling from laboratory to manufacturing scale. Boston Bioprocess provides bioprocess engineering expertise and technical support for customer implementations using Cauldron's hyper fermentation platform.

Strategic tierMinorTypeOthersAnnounced on2022-01-01
Description

Participated in UNSW Founders 10x Accelerator program during company formation. Provides startup ecosystem support, mentorship, and network access for early-stage development.

Recent move8 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
1Culture Biosciences
TypeDirect peer
Description

US-based fermentation contract development and manufacturing organization offering bioreactor services from lab to pilot scale. Directly comparable to Cauldron's FermaFit and FermaValidate tiers in serving synbio companies needing external fermentation capacity.

TypeDirect peer
Description

Precision fermentation CDMO providing end-to-end services from strain engineering to commercial manufacturing. Closely comparable CDMO business model targeting synbio customers needing scale-up support.

TypeDirect peer
Description

Vertically integrated synthetic biology company offering precision fermentation manufacturing services across food, flavor, fragrance, cosmetics, and pharma. Comparable as a precision fermentation CDMO with proprietary strain and process IP.

TypeDirect peer
Description

China-based synthetic biology platform combining strain engineering with fermentation scale-up and manufacturing services. Comparable CDMO offering targeting industrial precision fermentation customers.

TypeBroad incumbent
Description

US-listed synthetic biology platform with cell engineering and fermentation capabilities acquired through Zymergen. Broad incumbent in the synbio space whose 'Foundry' competes for the same upstream customer pipeline as Cauldron.

TypeEmerging player
Description

Animal-free dairy protein producer using precision fermentation. Comparable as a downstream precision fermentation customer/operator; overlaps with Cauldron on technology stack and customer segment but is also a potential FermaGrow customer rather than purely a competitor.

TypeEmerging player
Description

Carbon-capture gas fermentation company operating commercial-scale bioreactors. Comparable in scaling non-traditional continuous fermentation processes to industrial volumes and in winning government/defense funding.

TypeBroad incumbent
Description

US-listed enzyme engineering and biocatalysis company with proprietary fermentation and screening capabilities. Adjacent incumbent in industrial biomanufacturing serving pharma and food customers.

TypeRegional player
Description

India-based biologics and fermentation CDMO with continuous bioprocessing expertise. Comparable contract manufacturer with continuous manufacturing capabilities, primarily serving Asia-Pacific markets.

TypeBroad incumbent
Description

North American CDMO with microbial fermentation capabilities serving pharma, food, and industrial biotech customers. Comparable established contract manufacturer that Cauldron's US facility would compete with regionally.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat6 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers1 record

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment1 record

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile2 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature3 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles4 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds6 records

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors8 records

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Cauldron Ferm

Precision Fermentation Contract Manufacturingcauldronferm.com

Cauldron Ferm is an Australian precision fermentation contract manufacturer that uses its proprietary continuous hyper-fermentation platform to help synthetic biology companies scale food proteins, functional ingredients, and bio-based products from laboratory to commercial production.

What Cauldron Ferm does

Cauldron Ferm is an Australian precision fermentation biomanufacturing company founded in 2022 in Orange, NSW, that operates a contract manufacturing platform enabling synthetic biology companies to scale fermentation processes from laboratory to commercial production. The company's core offering is a proprietary "hyper-fermentation" continuous biomanufacturing technology — a continuous fermentation platform that addresses two chronic limitations of traditional fed-batch fermentation: contamination risk and genetic drift during extended runs. The platform is paired with ACE media, a set of fully defined, organism-specific nutrient formulations designed to prevent contamination in continuous culture. Together, these components underpin three tiered services: FermaFit (lab-scale technical fit evaluation), FermaValidate (10kL scale-up and techno-economic validation), and FermaGrow (commercial-scale production at 100kL+), with the company claiming 30-50% lower operational expenditure and 45% lower capital expenditure than incumbent batch fermentation.

The company monetizes primarily through multi-year enterprise contract manufacturing agreements, with a secondary stream from licensing its globally commercialized hyper-fermentation IP — acquired from Agritechnology in 2022, representing the product of 35 years of R&D. Pricing is quote-based across the three service tiers. The customer base is horizontal within synthetic biology — food protein developers, functional ingredient companies, and producers of animal-free compounds — with Nourish Ingredients (animal-free fats and proteins) disclosed as the first customer in 2023. Cauldron operates a 25,000-liter demonstration facility in Orange and is developing the Cauldron Bio-fab in Mackay, Queensland, intended to be Asia-Pacific's largest end-to-end precision fermentation contract manufacturer at 1,000+ tonnes/year.

The company has raised approximately $26 million in equity across four rounds (2023 seed, 2024 Series A, 2026 Series A2) led by Main Sequence Ventures and Horizons Ventures, with participation from SOSV, In-Q-Tel, and NGS Super. It has additionally secured roughly $8.9 million in non-dilutive government funding from the Australian Industry Growth Program, the U.S. Department of Defense, and Business.gov.au. Cauldron was recognized as a 2025 World Economic Forum Technology Pioneer and ranked #9 on Fast Company's Most Innovative Companies in Asia-Pacific 2026.

Cauldron Ferm firmographics

Firmographics
Name
Cauldron Ferm
Legal name
Cauldron Molecules Pty Ltd
Website
https://cauldronferm.com
Company type
Private
Founded year
2022
Operating status
Operating
Headcount range
11–50 employees
Short description
Cauldron Ferm is an Australian precision fermentation contract manufacturer that uses its proprietary continuous hyper-fermentation platform to help synthetic biology companies scale food proteins, functional ingredients, and bio-based products from laboratory to commercial production.
Ownership category
akta.pro rank

Cauldron Ferm industry classification

Industry
Product category
Precision Fermentation Contract Manufacturing
NAICS
Beverage Manufacturing (3121)
SIC
Beverages (2080)
akta.pro industry
PRIMARYAFAFAIAG
Fermented/Probiotic Beverage Co-Packing (Kombucha, Kefir, Culture Drinks)
Agriculture & Food Production/Beverage Production/Contract Beverage Manufacturing & Co-Packing
SECONDARYAFAFAHAJ
Fermented Beverage Contract Manufacturing & Private Label
Agriculture & Food Production/Beverage Production/Fermented Beverage Production (Kombucha, Kefir, Probiotics)

Keywords

  • Precision fermentation services
  • Contract biomanufacturing
  • Continuous fermentation platform
  • Synthetic biology manufacturing
  • Bioprocess scale-up

Where Cauldron Ferm is headquartered

Location

Headquarters

HQ city
Borenore
HQ country
Australia
HQ region
Oceania

Offices2 records

Markets served

Cauldron Ferm business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Technology or R&D, Operations, Personnel, Infrastructure, Marketing or Sales

Revenue model

  1. Contract Biomanufacturing Services: Fee-for-service contract manufacturing using proprietary hyper fermentation platform. Provides three service tiers: FermaFit (technology evaluation), FermaValidate (10kL validation), and FermaGrow (commercial-scale production at 100kL+).
  2. Technology Licensing: Licensing of proprietary hyper fermentation technology and IP acquired in 2022 seed round, now globally commercialized.

Pricing tiers

ModelBillingPrice
OtherMulti-year contractFermaFit - Technology evaluation tier
OtherMulti-year contractFermaValidate - 10kL validation tier
OtherMulti-year contractFermaGrow - Commercial-scale production tier

Go-to-market motion1 record

Distribution channels3 records

Marketing channels4 records

Cauldron Ferm product offering

Product offering

Core offering

Cauldron Ferm provides contract biomanufacturing services for precision fermentation, scaling customer fermentation processes from laboratory to commercial volumes using a proprietary continuous hyper-fermentation platform. Services are delivered through three tiers — FermaFit (technology evaluation), FermaValidate (10kL scale validation), and FermaGrow (100kL+ commercial production) — and supported by ACE media and proprietary bioprocess protocols. The company also licenses its hyper-fermentation technology IP for global commercialization.

Product overview

Cauldron Ferm offers a platform-plus-services model for precision fermentation biomanufacturing. The core is its proprietary hyper-fermentation technology (continuous fermentation that solves contamination and genetic drift challenges), paired with ACE media (optimized growth media formulations). Services are delivered through three tiers: FermaFit (lab-scale technology transfer and technical fit evaluation), FermaValidate (10kL scale-up validation with techno-economic analysis), and FermaGrow (commercial-scale production at 100kL). The company operates demonstration facilities in Orange, NSW and is developing a commercial-scale facility in Mackay, Queensland.

Differentiator

Problem solved

Functional benefit

Brands

  • FermaFit: Technology transfer and evaluation of technical fit service for customers to transfer their technology and assess compatibility with Cauldron's continuous fermentation process.
  • FermaValidate
  • FermaGrow
  • Cauldron Bio-fab

Products and services

  • FermaFit Technology transfer and evaluation service that assesses the technical fit of a customer's micro-organism with Cauldron's hyper-fermentation platform at lab-scale, including ACE media compatibility assessment. Targeted at precision fermentation companies beginning their scale-up journey.
  • FermaValidate Scale-up validation service at 10,000-litre scale that optimizes hyper-fermentation conditions and validates the techno-economic benefits for a customer's specific micro-organism, including COGS and output projections at 100kL scale. Targeted at synthetic biology companies ready to validate production economics before commercial-scale commitment.
  • FermaGrow Commercial-scale contract manufacturing service using hyper-fermentation to deliver low-cost production and commercial volumes at price parity with conventional products at 100,000-litre-plus capacity. Targeted at synthetic biology companies commercializing precision-fermented food proteins, ingredients, and other bio-based products.

Quantifiable outcome

  • 30-50% reduction in operational costs compared to traditional batch fermentation
  • +3 more outcomes

Companies that use Cauldron Ferm

Customer profile

Named customers1 record

Segments1 record

Ideal customer profiles2 records

Cauldron Ferm technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature3 records

Cauldron Ferm partnerships and signals

Strategic signal

Partnerships

Three partnerships are on record, tiered core and minor.

  • Mackay BioFutures HubcoreStrategic or Co-development Partner · 1 January 2024Partnership for bioeconomy development at Mackay facility location. Provides infrastructure access and ecosystem positioning for first industrial-scale hyper fermentation facility.
  • Boston BioprocesscoreStrategic or Co-development Partner · 1 January 2023Strategic partnership for scaling from laboratory to manufacturing scale. Boston Bioprocess provides bioprocess engineering expertise and technical support for customer implementations using Cauldron's hyper fermentation platform.
  • UNSW Founders 10x AcceleratorminorOthers · 1 January 2022Participated in UNSW Founders 10x Accelerator program during company formation. Provides startup ecosystem support, mentorship, and network access for early-stage development.

Scale indicators8 records

Recent moves8 records

Expansion highlights6 records

Cauldron Ferm competitors and assessment

Company assessment

Direct peers

  • Culture Biosciences: US-based fermentation contract development and manufacturing organization offering bioreactor services from lab to pilot scale. Directly comparable to Cauldron's FermaFit and FermaValidate tiers in serving synbio companies needing external fermentation capacity.
  • Solar Biotech: Precision fermentation CDMO providing end-to-end services from strain engineering to commercial manufacturing. Closely comparable CDMO business model targeting synbio customers needing scale-up support.
  • Conagen: Vertically integrated synthetic biology company offering precision fermentation manufacturing services across food, flavor, fragrance, cosmetics, and pharma. Comparable as a precision fermentation CDMO with proprietary strain and process IP.
  • Bota Bio: China-based synthetic biology platform combining strain engineering with fermentation scale-up and manufacturing services. Comparable CDMO offering targeting industrial precision fermentation customers.

Broad incumbents

  • Ginkgo Bioworks: US-listed synthetic biology platform with cell engineering and fermentation capabilities acquired through Zymergen. Broad incumbent in the synbio space whose 'Foundry' competes for the same upstream customer pipeline as Cauldron.
  • Codexis: US-listed enzyme engineering and biocatalysis company with proprietary fermentation and screening capabilities. Adjacent incumbent in industrial biomanufacturing serving pharma and food customers.
  • BioVectra: North American CDMO with microbial fermentation capabilities serving pharma, food, and industrial biotech customers. Comparable established contract manufacturer that Cauldron's US facility would compete with regionally.

Emerging players

  • Perfect Day: Animal-free dairy protein producer using precision fermentation. Comparable as a downstream precision fermentation customer/operator; overlaps with Cauldron on technology stack and customer segment but is also a potential FermaGrow customer rather than purely a competitor.
  • LanzaTech: Carbon-capture gas fermentation company operating commercial-scale bioreactors. Comparable in scaling non-traditional continuous fermentation processes to industrial volumes and in winning government/defense funding.

Regional players

  • Enzene Biosciences: India-based biologics and fermentation CDMO with continuous bioprocessing expertise. Comparable contract manufacturer with continuous manufacturing capabilities, primarily serving Asia-Pacific markets.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat6 records

Key risks6 records

Key highlights7 records

Customer concentration

Cauldron Ferm social profiles

Digital presence

Cauldron Ferm financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Cauldron Ferm leadership team

Management profile

Number of profiles

Profiles4 records

Cauldron Ferm funding detail

Funding detail

Funding overview

Funding rounds6 records

Investors8 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Cauldron Ferm M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Cauldron Ferm

What does Cauldron Ferm do?

Cauldron Ferm provides contract biomanufacturing services for precision fermentation, scaling customer fermentation processes from laboratory to commercial volumes using a proprietary continuous hyper-fermentation platform. Services are delivered through three tiers — FermaFit (technology evaluation), FermaValidate (10kL scale validation), and FermaGrow (100kL+ commercial production) — and supported by ACE media and proprietary bioprocess protocols. The company also licenses its hyper-fermentation technology IP for global commercialization.

Is Cauldron Ferm a public or private company?

Cauldron Ferm is a private company. It is classified as venture growth investor backed and is currently operating.

When was Cauldron Ferm founded?

Cauldron Ferm was founded in 2022. It employs 11 to 50 people.

Where is Cauldron Ferm based?

Cauldron Ferm is headquartered in Borenore, Australia, in the Oceania region.

How does Cauldron Ferm make money?

Two revenue lines are on record. Contract Biomanufacturing Services are the primary driver. The others are technology Licensing.

Who are Cauldron Ferm's main competitors?

Direct peers on record are Culture Biosciences, Solar Biotech, Conagen and Bota Bio. Broad incumbents are Ginkgo Bioworks, Codexis and BioVectra. Emerging players are Perfect Day and LanzaTech. Enzene Biosciences is listed as a regional player.

Does Cauldron Ferm have an API?

No public API is recorded for Cauldron Ferm.

What industry is Cauldron Ferm in?

Cauldron Ferm's product category is Precision Fermentation Contract Manufacturing. Its primary akta.pro industry code is AFAFAIAG, Fermented/Probiotic Beverage Co-Packing (Kombucha, Kefir, Culture Drinks), with a secondary code of AFAFAHAJ, Fermented Beverage Contract Manufacturing & Private Label. Its NAICS code is 3121 and its SIC code is 2080.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
Food & Drink BusinessLatest IGP grants awarded as program goes on hiatusThe federal government released the latest round of Industry Growth Program grants, including $1.7M for A-Culture Holding, $1.38M for Algenie, and $2.2M for VeraSys. The program, which has dispensed $201.5 million of $392 million to 133 companies, is on indefinite hiatus after the 2026 Budget. The pause follows CSIRO restructuring and uncommitted fund savings.The StrategistChina is bolstering food security with biomanufacturing. Australia should, tooChina is building at least 43 new pilot biomanufacturing plants focused on key food inputs as part of its strategy to reduce economic vulnerability and strengthen food security under President Xi Jinping's direction, with facilities including a first-of-its-kind factory the size of 50 football pitches operated by Angel Yeast. The United States has similarly elevated biotechnology in its national security agenda through a landmark report by the National Security Commission on Emerging Biotechnology and a new partnership between the departments of agriculture and defence. The article argues Australia should follow suit by developing a coordinated national biomanufacturing strategy, noting its competitive companies Cauldron Ferm and Vow, A$1.1 billion biofuel investment, and access to domestic feedstocks, while warning that fragmented investments without a coherent strategy fall short of the resilience needed to protect national security.edieAI Drives New Wave of Sustainability Innovation: Innovations of The MonthThis article compiles six environmental innovation stories from April, covering AI tools for ESG reporting, sustainable 3D concrete printing, vacuum-insulated glazing, long-duration flywheel energy storage, continuous biomanufacturing, and carbon storage using mine waste. The featured innovations span multiple sectors including construction, energy, and manufacturing, with companies like Briink, V-Glass, Qnetic, and Cauldron Ferm actively developing new technologies backed by recent funding rounds. A Singapore-based research partnership involving NUS and Woh Hup demonstrated structural 3D concrete printing with 40 per cent manpower savings, while a Concordia University study found mine slag can capture up to 99.5 per cent of injected CO2.Food & Drink BusinessLatest IGP grants awardedThe federal Industry Growth Program awarded $6.9 million to five applicants, including Bioborne, C Sea Solutions, Seascape Restorations Australia, and Levur. The program has dispensed $177.3 million of $392 million to 116 companies since November 2023.WorldbiomarketinsightsCauldron raises $13.25 M to scale continuous fermentation techAustralian biomanufacturing company Cauldron Ferm announced a $13.25 million Series A2 funding round led by Main Sequence Ventures, with participation from Horizons Ventures, SOSV, and pension fund NGS Super, bringing total funding to $26 million since its 2022 founding. The company has developed continuous fermentation technology that keeps microbes productive for extended periods, unlike traditional batch processing cycles, and has demonstrated the system at 10,000-liter scale. Cauldron is now working with corporate partners to retrofit existing industrial facilities with its technology, targeting the projected transformation where up to 60% of physical inputs to the global economy could eventually be produced biologically.Pulse 2.0Cauldron Ferm: $13.25 Million Raised For Biomanufacturing Platform ExpansionCauldron Ferm raised $13.25 million in a Series A2 funding round led by Main Sequence Ventures, with participation from Horizons Ventures, SOSV, and NGS Super, bringing its total funding to $26 million. The capital will be used to expand the company's proprietary continuous hyper-fermentation platform for industrial-scale biomanufacturing, which enables continuous production of bio-based products at lower costs than traditional methods. The company has demonstrated its technology at 10,000 liters and operates a 30,000-liter demonstration facility in Orange, Australia.GoogleAustralia’s Cauldron Ferm Gets $13.25M for Continuous ‘Hyper-Fermentation’ PlatformAustralian biomanufacturing startup Cauldron Ferm has raised $13.25 million in Series A2 funding, led by Main Sequence Ventures with participation from Horizons Ventures, SOSV and NGS Super, bringing total raised to $26 million. The company says its continuous "hyper-fermentation" platform cuts net unit costs by up to 50% and delivers 20% more output with 45% less capex. It plans a 500,000-litre Mackay plant and global facility network.GreenqueenAustralia’s Cauldron Ferm Gets $13.25M for Continuous ‘Hyper-Fermentation’ PlatformAustralian biomanufacturing startup Cauldron Ferm has raised $13.25M in Series A2 funding, led by Main Sequence Ventures with participation from Horizons Ventures, SOSV, and NGS Super, to expand its continuous "hyper-fermentation" technology platform. The company's proprietary process lowers unit costs by up to 50% and delivers 20% more output with 45% less capex compared to conventional fed-batch fermentation methods. Cauldron plans to use the funding to build a 500,000-litre commercial-scale facility in Mackay, Queensland, and develop a global network of industrial facilities through retrofitted sites.TechCrunchCauldron Ferm has turned microbes into nonstop assembly linesCauldron Ferm has raised $13.25 million in a Series A2 funding round led by Main Sequence Ventures with participation from Horizons Ventures, NGS Super, and SOSV, bringing its total funding to $19.75 million. The company's hyper fermentation technology enables continuous microbial protein production by keeping microbes in their maximally productive state, addressing the cost and scalability limitations of traditional batch fermentation processes. The startup, which currently produces fats and proteins including whey protein, plans to use the funding to expand its technology moat and diversify beyond food into other sectors where 60% of global economy inputs could be produced biologically.Sosv4 SOSV Companies Named to Fast Company's Most Innovative Companies of 2026 ListFive SOSV portfolio companies were named to Fast Company's Most Innovative Companies of 2026 list. The companies include Cauldron Ferm, Bactery, Everbloom, and Puna Bio, each recognized for innovations in biomanufacturing, soil-powered batteries, sustainable wool, and extremophile bio-fertilizers.